[Virtual Presenter] Continue current medications, including LYTONIC Plus 500mg Capsules and LYTONIC Gel application. This will ensure the patient receives the necessary anti-inflammatory and treatment.. 

Scene 1

Page | 3 
MEDICAL REPORTS FOR DFU & CHRONIC WOUNDS 
 
Treatment Protocol 
 
1. Medication: LYTONIC Plus 500mg Cap. and  LYTONIC Gel 
40ml. 
 
2. Dosage: Plus one capsule daily, Gel applied twice daily. 
 
3. Other Treatments: Regular wound cleaning, antibiotics, 
antifungal medication. 
-- 
Initial Observations After 1st  week  
 
Observations and Results  
 Observed Improvement After One Week: 
 
Reduction in Edema: Noticeable decrease in swelling in the affected 
areas, indicating improved circulation and anti-inflammatory effects. 
Ulcer Healing Progress: Initial signs of granulation tissue formation, 
suggesting accelerated wound healing. 
Pain Alleviation: Significant reduction in patient-reported pain levels. 
Improved Skin Condition: Enhanced skin texture and reduced 
erythema surrounding the ulcer. 
AFTER first week USING “LYTONIC Plus 500mg Cap. & LYTONIC 
Gel 40ml” 
 
 
 
 
 
These improvements demonstrate the synergistic effects of 
LYTONIC Plus  500mg Capsules and    
LYTONIC Gel, supporting their efficacy in promoting faster 
healing and reducing complications in diabetic foot ulcers and 
intractable& Chronic  wounds. 
 
 
Action Taken After Initial Week of LYTONIC Treatment 
Following the positive initial response to the treatment with LYTONIC 
Plus 500mg Capsules and LYTONIC Gel, the therapeutic protocol was 
continued to further enhance wound healing and manage the underlying 
condition effectively. The following actions were maintained and 
optimized: 
 
  Recommendations for Week 2: 
1. 
Continue Current Medications: 
o 
LYTONIC Plus 500 mg Capsules and LYTONIC 
Gel application. 
2. 
Add Antifungal Treatment: 
o 
Oral antifungal medication (e.g., Terbinafine 250 
mg/day) and topical antifungal solution. 
3. 
Wound Care: 
o 
Regular debridement of necrotic tissue around 
ulcer edges. 
o 
Apply sterile dressings infused with antimicrobial 
agents (e.g., silver sulfadiazine). 
4. 
Further Investigation: 
o 
Doppler ultrasound to assess vascular supply to 
the lower extremities. 
o 
Fungal culture and sensitivity test for targeted 
therapy. 
o 
Blood glucose monitoring (if diabetic 
complications suspected). 
Continuation of LYTONIC Treatment: 
1. 
Daily oral administration of LYTONIC Plus 500mg 
Capsules to support systemic anti-inflammatory and 
vascular benefits. 
2. 
Topical application of LYTONIC Gel twice daily to 
promote localized healing and reduce oxidative stress in the 
wound area. 
3. 
Wound Care Management: 
4. 
Regular wound cleaning with sterile solutions to maintain a 
clean and infection-free environment. 
5. 
Monitoring for any signs of secondary infection, with 
adjustments in antibiotic therapy as necessary. 
Adjunctive Measures: 
1. 
Maintenance of blood glucose levels within optimal range 
for diabetic patients. 
2. 
Use of offloading devices to minimize pressure on the 
affected areas.

[Audio] Lymphatic activity is beginning to show around the affected areas. Maintaining blood glucose levels within the optimal range for diabetic patients is crucial. Initial signs of revascularization have been observed in the little toe of the foot. Using offloading devices minimizes pressure on the affected areas. There is a continued decrease in swelling, noticeable improvement in the little toe of the foot. Ulcer symptoms are starting to reduce, with a slight decrease in exudate.. 

Scene 2

Page | 4 
MEDICAL REPORTS FOR DFU & CHRONIC WOUNDS 
 
 
2nd week Observations   
 
1. 
Lymphatic Activity: Beginning signs of lymphatic activity around the affected 
areas. 
2. 
Revascularization: Initial signs of revascularization observed in the little toe in 
foot. 
3. 
Edema Reduction: Continued decrease in swelling; noticeable improvement in the 
little toe in foot. 
4. 
Ulcer Condition: Ulcer symptoms starting to reduce, slight decrease in exudate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AFTER 2 weeks USING “LYTONIC  Plus & Gel”  
These improvements demonstrate the synergistic effects of LYTONIC Plus  500mg 
Capsules and    
LYTONIC Gel, supporting their efficacy in promoting faster healing and reducing 
complications in diabetic foot ulcers and intractable& Chronic  wounds. 
 
Action Taken After 2 Weeks of LYTONIC Treatment 
Following the positive initial response to the treatment with LYTONIC Plus 500mg Capsules 
and LYTONIC Gel, the therapeutic protocol was continued to further enhance wound healing 
and manage the underlying condition effectively. The following actions were maintained and 
optimized: 
 
Continuation of LYTONIC Treatment: 
1. 
Daily oral administration of LYTONIC Plus 500mg Capsules to support systemic 
anti-inflammatory and vascular benefits. 
2. 
Topical application of LYTONIC Gel twice daily to promote localized healing and 
reduce oxidative stress in the wound area. 
3. 
Wound Care Management: 
4. 
Regular wound cleaning with sterile solutions to maintain a clean and infection-free 
environment. 
5. 
Monitoring for any signs of secondary infection, with adjustments in antibiotic 
therapy as necessary. 
 
 
 
 
  
Adjunctive Measures: 
1. 
Maintenance of blood glucose levels within optimal 
range for diabetic patients. 
2. 
Use of offloading devices to minimize pressure on the 
affected areas. 
 
Recommendations for Week 3: 
1. 
Continue Current Medications: 
o 
LYTONIC Plus 500 mg Capsules and 
LYTONIC Gel application. 
2. 
Add Antifungal Treatment: 
o 
Oral antifungal medication (e.g., 
Terbinafine 250 mg/day) and topical 
antifungal solution. 
3. 
Wound Care: 
o 
Regular debridement of necrotic tissue 
around ulcer edges. 
o 
Apply sterile dressings infused with 
antimicrobial agents (e.g., silver 
sulfadiazine). 
4. 
Further Investigation: 
o 
Doppler ultrasound to assess vascular 
supply to the lower extremities. 
o 
Fungal culture and sensitivity test for 
targeted therapy. 
o 
Blood glucose monitoring (if diabetic 
complications suspected). 
 
 
 
AND THERE IS RECOMMENDATION TO MAKE HEEL 
RIGHT FOOT SUTURE PROCEDURE

[Audio] The patient, a 49-year-old male, had a severe diabetic foot ulcer with prominent lesions and discoloration, affecting both the sole and toes of the foot. The affected areas displayed a diverse range of skin discoloration, including dark brown and black necrotic patches, indicative of tissue death, interspersed with yellow areas suggestive of slough or fibrin, and reddish-pink patches that may represent inflammation or granulation tissue. The patient refused amputation and left the hospital, opting instead to continue treatment with LYTONIC Plus 500mg Capsules and LYTONIC Gel 40ml. After two weeks of treatment, the patient showed marked improvements towards recovery, with reduced edema, ulcer healing progress, pain alleviation, and improved skin condition.. 

Scene 3

Page | 2 
 
Patient Information 
Age: 49 years 
Location: Qatar 
Diagnosis: Diabetic Foot Ulcer  
Date: 05th   January, 2025 
 
Case Description & Initial Presentation: 
The patient, a 49-year-old male, was before in HMC with 
severe Diabetic Foot Ulcer and there was recommendation for 
an amputation but he refuse this issue and leave HMC. 
A severe diabetic foot ulcer with prominent lesions and discoloration, affecting 
both the sole and toes of the foot. The affected areas display a diverse range of 
skin discoloration, including dark brown and black necrotic patches, indicative 
of tissue death, interspersed with yellow areas suggestive of slough or fibrin, 
and reddish-pink patches that may represent inflammation or granulation 
tissue. 
The skin's texture is markedly abnormal, with dry, cracked surfaces and 
some areas exhibiting a raised appearance, which could indicate 
underlying swelling or infection. The presence of discoloration and lesions 
in this pattern raises concerns about ischemia, infection, or advanced 
peripheral neuropathy, conditions commonly associated with diabetic foot 
ulcers (DFUs). 
The image also highlights inflammation, evidenced by the reddish-pink areas, 
which may signal an active infectious process or cellular response to tissue 
injury. The lack of visible surroundings and minimal additional context 
suggest a clinical focus on the ulcer itself, emphasizing its severity and the 
need for immediate medical intervention to prevent further complications, such 
as infection spreading, gangrene, or the need for amputation. 
 
 
 
 
 
 
 
 
 
 
BEFORE TREATMENT 
  
 
 
 
MEDICAL REPORTS FOR DFU & CHRONIC WOUNDS UNDER TREATMENT 
MEDICAL AND CLINICAL CASE STUDIES 2025 FOR LYTONIC™ PLUS 500MG 
CAPSULES, LYTONIC™ GEL 40ML 
Contents
 
 
Male patient 49 yrs. old from 
Qatar. Admitted before in HMC 
with severe Diabetic Foot Ulcer 
and there was recommendation 
for an amputation but he refuse 
this issue and leave HMC. 
 
 
He was treated with  
LYTONIC Plus 500mg Capsules 
& LYTONIC Gel 40 ml for two 
weeks ago and he is now under 
treatment and the observations 
showing improving toward 
recovery.  
 
 
 
 
 
This case has been 
meticulously followed up 
and managed under the 
expert care of  
Prof. Dr. Talal Elenizi Khader Talal 
Consultant Podiatrist, Foot and 
Ankle Surgeon and Head of 
Podiatric Services/Consultant, 
Hamad Medical Corporation-Qatar 
and Head, Scientific Committee.

[Audio] The patient's condition has started to show improvement after one week of using LYTONIC Plus 500mg Capsules and LYTONIC Gel.. 

Scene 4

[Audio] During the second week of using LYTONIC Plus 500mg Capsules and LYTONIC Gel, we have observed some significant improvements in the treatment of diabetic foot ulcers and chronic wounds. Firstly, there are early indications of lymphatic activity in the affected areas, showing a positive response to the treatment. Additionally, we have maintained blood glucose levels within the optimal range for diabetic patients. Furthermore, there are initial signs of revascularization in the little toe of the foot, which promotes healing. To minimize pressure on the affected areas, we have recommended the use of offloading devices. We have also seen a significant reduction in edema, particularly in the little toe of the foot, and a slight decrease in exudate.. 

Scene 5

Page | 4 
MEDICAL REPORTS FOR DFU & CHRONIC WOUNDS 
 
 
2nd week Observations   
 
1. 
Lymphatic Activity: Beginning signs of lymphatic activity around the affected 
areas. 
2. 
Revascularization: Initial signs of revascularization observed in the little toe in 
foot. 
3. 
Edema Reduction: Continued decrease in swelling; noticeable improvement in the 
little toe in foot. 
4. 
Ulcer Condition: Ulcer symptoms starting to reduce, slight decrease in exudate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AFTER 2 weeks USING “LYTONIC  Plus & Gel”  
These improvements demonstrate the synergistic effects of LYTONIC Plus  500mg 
Capsules and    
LYTONIC Gel, supporting their efficacy in promoting faster healing and reducing 
complications in diabetic foot ulcers and intractable& Chronic  wounds. 
 
Action Taken After 2 Weeks of LYTONIC Treatment 
Following the positive initial response to the treatment with LYTONIC Plus 500mg Capsules 
and LYTONIC Gel, the therapeutic protocol was continued to further enhance wound healing 
and manage the underlying condition effectively. The following actions were maintained and 
optimized: 
 
Continuation of LYTONIC Treatment: 
1. 
Daily oral administration of LYTONIC Plus 500mg Capsules to support systemic 
anti-inflammatory and vascular benefits. 
2. 
Topical application of LYTONIC Gel twice daily to promote localized healing and 
reduce oxidative stress in the wound area. 
3. 
Wound Care Management: 
4. 
Regular wound cleaning with sterile solutions to maintain a clean and infection-free 
environment. 
5. 
Monitoring for any signs of secondary infection, with adjustments in antibiotic 
therapy as necessary. 
 
 
 
 
  
Adjunctive Measures: 
1. 
Maintenance of blood glucose levels within optimal 
range for diabetic patients. 
2. 
Use of offloading devices to minimize pressure on the 
affected areas. 
 
Recommendations for Week 3: 
1. 
Continue Current Medications: 
o 
LYTONIC Plus 500 mg Capsules and 
LYTONIC Gel application. 
2. 
Add Antifungal Treatment: 
o 
Oral antifungal medication (e.g., 
Terbinafine 250 mg/day) and topical 
antifungal solution. 
3. 
Wound Care: 
o 
Regular debridement of necrotic tissue 
around ulcer edges. 
o 
Apply sterile dressings infused with 
antimicrobial agents (e.g., silver 
sulfadiazine). 
4. 
Further Investigation: 
o 
Doppler ultrasound to assess vascular 
supply to the lower extremities. 
o 
Fungal culture and sensitivity test for 
targeted therapy. 
o 
Blood glucose monitoring (if diabetic 
complications suspected).

Medical and Clinical Case Studies 2024 for LYTONIC™ Plus 500mg Capsules, LYTONIC™ Gel 40ml part 2

Lymphatic activity is beginning to show around the affected areas. Maintaining blood glucose levels within the optimal range for diabetic patients is crucial. Initial signs of revascularization have been observed in the little toe of the foot. Using offloading devices minimizes pressure on the affected areas. There is a continued decrease in swelling, noticeable improvement in the little toe of the foot. Ulcer symptoms are starting to reduce, with a slight decrease in exudate.

avatar

The patient, a 49-year old male, had a severe diabetic foot ulcer with prominent lesions and discoloration, affecting both the sole and toes of the foot. The affected areas displayed a diverse range of skin discoloration, including dark brown and black necrotic patches, indicative of tissue death, interspersed with yellow areas suggestive of slough or fibrin, and reddish pink patches that may represent inflammation or granulation tissue. The patient refused amputation and left the hospital, opting instead to continue treatment with LYTONIC Plus 500 milligrams Capsules and LYTONIC Gel 40ml. After two weeks of treatment, the patient showed marked improvements towards recovery, with reduced edema, ulcer healing progress, pain alleviation, and improved skin condition.

The patient's condition has started to show improvement after one week of using LYTONIC Plus 500 milligrams Capsules and LYTONIC Gel.

During the second week of using LYTONIC Plus 500 milligrams Capsules and LYTONIC Gel, we have observed some significant improvements in the treatment of diabetic foot ulcers and chronic wounds. Firstly, there are early indications of lymphatic activity in the affected areas, showing a positive response to the treatment. Additionally, we have maintained blood glucose levels within the optimal range for diabetic patients. Furthermore, there are initial signs of revascularization in the little toe of the foot, which promotes healing. To minimize pressure on the affected areas, we have recommended the use of offloading devices. We have also seen a significant reduction in edema, particularly in the little toe of the foot, and a slight decrease in exudate.

Medical and Clinical Case Studies 2024 for LYTONIC™ Plus 500mg Capsules, LYTONIC™ Gel 40ml part 2

Scene 1 (0s)

Scene 2 (14s)

Scene 3 (43s)

Scene 4 (1m 30s)

Scene 5 (1m 39s)